NCT06751147

Brief Summary

The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

December 23, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

December 20, 2024

Last Update Submit

July 21, 2025

Conditions

Keywords

femoral neuropathy

Outcome Measures

Primary Outcomes (3)

  • quality of life is assessed by QOL questioner

    EQ-5D is used to measure quality of life

    at base line pre intervention, at the end of 4th week post intervention

  • Knee range of motion is used to measure ROM

    measured by goniometer

    at base line pre intervention, at the end of 4th week post intervention

  • neuropathic pain

    The Neuropathic Pain Scale (NPS) is a tool used to assess the specific qualities of pain associated with neuropathic pain. It helps differentiate neuropathic pain from other types of pain by evaluating different pain sensations and their intensity. The NPS consists of 10 items, each rated on a scale of 0 to 10, where 0 is "no pain" and 10 is the "worst imaginable pain".

    at base line pre intervention, at the end of 4th week post intervention

Study Arms (2)

group A

EXPERIMENTAL

Lateral Femoral cutaneous nerve mobilization with muscle energy techniques

Other: Group A

GROUP B

EXPERIMENTAL
Other: Experimental Group B

Interventions

Group AOTHER

It consists of 24 patients who were assessed by prone knee bend (PKB) test and knee range of motion was measured by goniometer. In addition to traditional physical therapy and muscle energy procedures, patients in this group received neural mobilization. The patient laid on their side with their knee bent to a 90-degree angle and the affected side looking up while neural mobilization was carried out. The therapist then performed the technique by abducting and extending the patient's hip. Five repetitions of the nerve stretch were performed, each with a 10-second hold and a 5-second rest in between. METs were implemented in two positions using post-isometric relaxation (PIR): In this initial posture, the patient laid on their back with the affected leg just over the bed's edge. With one hand, the physiotherapist stood facing the affected side and pressed the contralateral ASIS to keep the patient from rolling off the bed. The therapist, however, simultaneously grabbed the femur dist

group A

It involves 24 patients who had received the neural mobilization described above along with traditional physical therapy that does not involve muscular energy techniques. The treatment took place in the outpatient physical therapy department and lasted around thirty minutes in total

GROUP B

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspatients are of Pregnant females
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranges from 18 to 40 years
  • Body mass index ≥25kg/m2.
  • Pregnant females in third trimester diagnosed with myalgia paraesthetica.
  • Multigravida pregnant females
  • Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
  • Positive pelvic compression test(1)

You may not qualify if:

  • Those having other entrapment syndromes or radicular symptoms
  • Motor weakness
  • Having a history or ongoing cancerous proliferation
  • Active infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ghurkhi Hospital

Lahore, Punjab Province, Pakistan

Location

Ghurki Hospital

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Femoral Neuropathy

Condition Hierarchy (Ancestors)

MononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Iqra abdul ghafoor, PPDPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
outcome assessor was kept blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2024

First Posted

December 27, 2024

Study Start

December 23, 2024

Primary Completion

May 15, 2025

Study Completion

May 15, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations